Back to Journals » Drug Design, Development and Therapy » Volume 6

Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach

Total article views   Abstract views HTML views PDF downloads Totals
15,165 Dovepress* 10,885 632+ 2,665 11,517
PubMed Central* 44 3,604 1,572 3,648
Totals 10,929 4,236 4,237 15,165
*Since 19 July 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 2 7

View citations on PubMed Central and Google Scholar